Biomarin Pharmaceutical Inc (BMRN)
66.00
-0.60
(-0.90%)
USD |
NASDAQ |
Nov 04, 16:00
66.30
+0.30
(+0.45%)
Pre-Market: 08:51
Biomarin Pharmaceutical Net Income (Annual): 167.64M for Dec. 31, 2023
Net Income (Annual) Chart
Historical Net Income (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 167.64M |
| December 31, 2022 | 141.56M |
| December 31, 2021 | -64.08M |
| December 31, 2020 | 854.03M |
| December 31, 2019 | -23.85M |
| December 31, 2018 | -77.21M |
| December 31, 2017 | -117.04M |
| December 31, 2016 | -630.21M |
| December 31, 2015 | -171.80M |
| December 31, 2014 | -133.97M |
| December 31, 2013 | -176.35M |
| December 31, 2012 | -114.35M |
| December 31, 2011 | -53.84M |
| Date | Value |
|---|---|
| December 31, 2010 | 205.82M |
| December 31, 2009 | -0.488M |
| December 31, 2008 | 30.83M |
| December 31, 2007 | -15.80M |
| December 31, 2006 | -28.53M |
| December 31, 2005 | -74.27M |
| December 31, 2004 | -187.44M |
| December 31, 2003 | -75.80M |
| December 31, 2002 | -77.46M |
| December 31, 2001 | -67.61M |
| December 31, 2000 | -37.36M |
| December 31, 1999 | -28.07M |
| December 31, 1998 | -12.30M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (Annual) Range, Past 5 Years
-64.08M
Minimum
2021
854.03M
Maximum
2020
215.06M
Average
141.56M
Median
2022
Net Income (Annual) Benchmarks
| Merck & Co Inc | 365.00M |
| Bristol-Myers Squibb Co | 8.025B |
| Alnylam Pharmaceuticals Inc | -440.24M |
| Bioventus Inc | -156.23M |
| Moderna Inc | -4.714B |